Hjem › Kronisk myelogen leukemi
Kliniske studier for Kronisk myelogen leukemi rekrutterer i USA
48 studier for Kronisk myelogen leukemi rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Houston, TX18 studier
- Seattle, WA11 studier
- New York City, NY11 studier
- Detroit, MI6 studier
- Birmingham, AL6 studier
- Philadelphia, PA6 studier
- Chicago, IL6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Nashville, TN5 studier
- Columbus, OH5 studier
- Milwaukee, WI5 studier
- Baltimore, MD5 studier
- Atlanta, GA5 studier
- Boston, MA5 studier
- Durham, NC5 studier
- Rochester, NY4 studier
- Mountain View, CA4 studier
- Cincinnati, OH4 studier
- Kansas City, MO4 studier
- Augusta, GA4 studier
- Washington, DC4 studier
- St. Louis, MO4 studier
- Sacramento, CA3 studier
- Edison, NJ3 studier
- Salt Lake City, UT3 studier
- Cleveland, OH3 studier
- Orange, CA3 studier
- Miami, FL3 studier
- Bridgeport, CT3 studier
- Buffalo, NY3 studier
- Ann Arbor, MI3 studier
- Aurora, CO3 studier
- St. Petersburg, FL3 studier
- Greenville, NC3 studier
- Minneapolis, MN3 studier
Etter delstat
- Alabama6 studier
- Arizona4 studier
- California10 studier
- Colorado4 studier
- District of Columbia3 studier
- Florida7 studier
- Georgia7 studier
- Illinois6 studier
- Indiana3 studier
- Kansas5 studier
- Kentucky3 studier
- Maryland6 studier
- Massachusetts5 studier
- Michigan7 studier
- Minnesota4 studier
- Missouri4 studier
- Nebraska3 studier
- New Jersey4 studier
- New York15 studier
- North Carolina8 studier
- Ohio9 studier
- Oregon6 studier
- Pennsylvania7 studier
- Tennessee5 studier
- Texas18 studier
- Utah3 studier
- Virginia4 studier
- Washington11 studier
- Wisconsin5 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
RekruttererFase 1
Alder 18 til 120 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06904066Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
RekruttererObservasjonsstudie
Alder 0 til 38 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06131801Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT06817720Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
RekruttererFase 1/2
Alder 1 til 17 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT04925479Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07269470Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06236724Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2026 · NCT06398457Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
RekruttererFase 1
Alder 1 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT03630991Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 16. sep. 2026 · NCT01746836Study of Olverembatinib (HQP1351) in Patients With CML-CP
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06423911Cord Blood Transplant in Adults With Blood Cancers
RekruttererFase 2
Alder 21 til 65 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT05884333Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RekruttererFase 2
Alder 1 til 18 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07354074Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 27. aug. 2026 · NCT06523556Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
RekruttererFase 1
1 Day – 21 Years · Alle kjønn · Oppdatert 26. aug. 2026 · NCT05857969Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04838041TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
RekruttererFase 1
Alder 18 til 80 · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07302776Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
RekruttererFase 2
6 Months – 65 Years · Alle kjønn · Oppdatert 22. jul. 2026 · NCT06013423A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545Allo HSCT Using RIC and PTCy for Hematological Diseases
RekruttererFase 2
Opp til 75 år · Alle kjønn · Oppdatert 6. jul. 2026 · NCT05805605Asciminib Roll-over Study
RekruttererFase 4
Alder 7 til 100 · Alle kjønn · Oppdatert 6. jul. 2026 · NCT04877522Registry of Older Patients With Cancer
RekruttererObservasjonsstudie
Alder 65 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT01137825Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
RekruttererFase 2
Opp til 60 år · Alle kjønn · Oppdatert 25. jun. 2026 · NCT03314974Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2026 · NCT05549661Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT07638007Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.